Alcohol and Health: The biological vulnerability of the female body

For many decades, medicine has treated alcohol consumption as a largely "neutral" issue, developing guidelines based largely on studies conducted on male populations. This approach has produced an incomplete view of the real risks. However, scientific data consolidated in early 2026 marks a turning point: the female body exhibits a specific biological vulnerability to alcohol, faster and more severe than long believed.

This is not a matter of individual tolerance or willpower, but of biochemistry. Alcohol metabolism in women is influenced by well-documented physiological factors. Ethanol is a water-soluble substance, and the female body, on average, contains a higher percentage of fat and a lower amount of water compared to the male body. At equal weight and intake, alcohol is therefore more concentrated in the blood, causing faster intoxication and more intense exposure of vital organs.

This is compounded by a second crucial factor: women's stomachs have lower levels of alcohol dehydrogenase (ADH), the enzyme that begins ethanol breakdown before it enters the bloodstream. As a result, a greater portion of alcohol reaches the liver in unmetabolized form, increasing the toxic load from the very first stages of consumption.

One of the most alarming aspects emerging from the scientific literature is the so-called "telescoping" effect. This term describes the accelerated trajectory that characterizes women's relationship with alcohol: although they start drinking later on average than men, women develop dependence and related diseases in much shorter times. Liver cirrhosis, heart damage, and brain atrophy can manifest after significantly shorter periods of consumption, following a compressed and aggressive progression.

As highlighted by the New York Times as well, the problem goes beyond intoxication.

Even consumption defined as "moderate" interferes with the endocrine system, increasing estrogen levels. This mechanism is associated with an increased risk of breast carcinoma, making alcohol a particularly relevant oncogenic factor for women's health. Similarly, the idea of a cardiovascular protective effect from wine finds no confirmation in women: benefits are minimal or absent, while the risk of hypertension and cardiomyopathies rises even with low doses.

Alongside biological factors, a disturbing social dimension emerges.

Marketing in recent years has promoted the so-called "Wine Mom culture," normalizing alcohol use as a response to daily stress. This phenomenon has contributed to reducing the gender gap in consumption and to a significant increase in hospitalizations for alcoholic hepatitis among women aged 30 to 50.

The message from science is clear: there is no universal safe threshold. Prevention must account for biological differences and abandon neutral, simplified models.

Informing women about the specific risks linked to their physiology is today one of the most effective tools for protecting public health.

Credits: This article was originally written in Italian for ilmattino.it​